Article information
RESUMO
Com o aumento da esperança devida tem-se assistido a um envelhecimento da população mundial. Prevê-se que em 2050 o número de idosos duplique. Nesta faixa etária as doenças infecciosas são a causa mais frequente de hospitalização, sendo as infecções do tracto respiratório a quarta causa de morte no idoso e a principal causa de morbilidade.
Devido à idade, às múltiplas patologias, e ao frequente internamento em lares de 3ª idade, a etiologia e a clínica são substancialmente modificadas, obrigando-nos a atenções particulares no que concerne o diagnóstico e o tratamento.
REV PORT PNEUMOL 2001; VII (6): 485-493
Palavras-chave:
Pneumonia
idoso
ABSTRACT
With the increase in life expectancy, the world population is getting older. It is estimated that in 2050 the number of old people will double. In the aged, infectious diseases are the most common cause of hospitalization, the respiratory infections being the fourth cause of death and the main cause of morbidity.
Due to age, to the concomitance of multiple diseases and to frequent stay in nursing homes, etiology and clinic may be seriously modified, compelling us to pay a special attention to both diagnosis and treatment.
REV PORT PNEUMOL 2001; VII (6):
Key-words:
Pneumonia
elderly
Full text is only aviable in PDF
BIBLIOGRAFIA
[1.]
Stalam Malini, Kaye Donald.
Antibacterial Therapy: antibiotic agents in the elderly.
Infect D Clin North Am, 14 (2000),
[2.]
M.S. Niederman.
Nosocomial pneumonia in the elderly patient – chronic care facility and Hospital considerations.
Clin Chest Med, 14 (1993), pp. 479-490
[3.]
C. Feldman.
Pneumonia in the elderly.
Clin in Chest Med, 20 (1999), pp. 563-573
[4.]
A.M. Fein.
Pneumonia in the elderly: Special diagnostic and therapeutic considerations.
Med Clin North Am, 78 (1994), pp. 1015-1033
[5.]
CENTERS FOR DISEASE CONTROL: Pneumonia and Influenza death rates – United States, 1979-1994.
MMWR (Morbid Mortal Wkly Rep), 44 (1995), pp. 535-537
[7.]
K.B. Crossley, J.R. Turn.
Nursing home-acquired pneumonia.
Sem. Respir Infect, 4 (1989), pp. 64-72
[8.]
G.A. Harkness, D.W. Bentley, K.J. Roghmann.
Risk factors for nosocomial pneumonia in the elderly.
Am J Med, 89 (1990), pp. 457-463
[9.]
T.G. Emori, S.N. Banergee, D.H. Culver, et al.
Nosocomial infections in elderly patients in the United States, 1986-1990.
Am J Med, 91 (1991), pp. 289S-293S
[10.]
A.M. Fein.
Pneumonia in the elderly: overview of diagnostic and therapeutic approaches.
Clin Infect Dis, 28 (1999), pp. 726-729
[11.]
M.S. Niederman, A.M. Fein.
Pneumonia in the elderly.
Clin Geriatr Med, 2 (1986), pp. 241-268
[12.]
W.M. Valenti, R.G. Trudell, D.W. Bentley.
Factors predisposing to oropharyngeal colonization with Gram-negative bacilli in the aged.
N Engl J Med, 298 (1978), pp. 1108-1111
[13.]
GAMBOA T, RENDAS A: Fisiologia e Fisiopatologia respiratória no idoso. In Gomes MJM, Ávila R: Patologia Respiratória no idoso. Hospital de Pulido Valente, Faculdade de Ciências Médicas, Lisboa. pp 33-52
[14.]
R.L. Saltzman, P.K. Peterson.
Immunodeficiency of the elderly.
Rev Infect Dis, 9 (1987), pp. 1127-1138
[15.]
T.J. Marrie, H. Durant, L. Yates.
Community-acquired pneumonia requiring hospitalization: 5 year prospective study.
Rev Infect Dis., 11 (1989), pp. 586-599
[16.]
J.P. Metlay, R. Schulz, Y.H. Li, et al.
Influence of age on symptoms at presentation in patients with community-acquired pneumonia.
Arch Intern Med, 157 (1997), pp. 1453-1459
[17.]
A.M. Fein, S.H. Feinsilver, M.S. Niederman.
Atypical manifestations of pneumonia in the elderly.
Lin Chest Med, 12 (1991), pp. 319-336
[18.]
J.P. Lynch, F.J. Martinez.
Community-acquired pneumonia.
Current Opinion in Pulm Med, 4 (1998), pp. 161-172
[19.]
J.P. Mc Fadden, R.C. Price, H.D. Eastwood, et al.
Raised respiratory rate in elderly patients: A valuable physical sign.
BMJ, 284 (1982), pp. 626-627
[20.]
T.J. Marrie, E.V. Haldane, R.S. Faulkner, H. Durant, C. Kwan.
Community-acquired pneumonia requiring hospitalization. Is it different in the elderly?.
J Am Geriatr Soc, 33 (1985), pp. 671-680
[21.]
J.L. Garb, R.B. Brown, J.R. Garb, et al.
Differences in etiology of pneumonias in nursing-home and community patients.
JAMA, 240 (1978), pp. 2169-2172
[22.]
T.J. Marrie, H. Durant, C. Kwan.
Nursing home-acquired pneumonia. A case-control study.
J Am Geriatr Soc, 34 (1986), pp. 697-702
[23.]
O. Leroy, C. Santre, C. Beuscart, et al.
A five-year study of severe community-acquired pneumonia with enphasis on prognosis in patients admitted to na intensive care unit.
Intensive Care Med, 21 (1995), pp. 24-31
[24.]
P. Moine, J.-B. Vercken, S. Chevret, et al.
Severe community-acquired pneumonia. Etiology, epidemiology, and prognosis factors.
Chest, 105 (1994), pp. 1487-1495
[25.]
U. Pachon, M.D. Parados, F. Capote, et al.
severe community-acquired pneumonia. Etiology, prognosis and treatment.
Am Rev Respir Dis, 142 (1990), pp. 369-373
[26.]
M.J. Fine, D.N. Smith, D.E. Singer.
Hospitalization decision in patients with community-acquired pneumonia: A prospectiv cohort study.
Am J Med, 89 (1990), pp. 713-720
[27.]
F.L. Brancati, J.W. Chow, M.W. Wagener, et al.
Is pneumonia really the old man's friend? Two-year prognosis after community-acquired pneumonia.
Lancet, 342 (1993), pp. 30-33
[28.]
T.J. Marrie.
Epidemiology of community-acquired pneumonia in the elderly.
Sem Resp Infect, 5 (1990), pp. 260-268
[29.]
M.S. Houston, M.D. Silverstein, V.J. Suman.
Risk factors for 30-day mortality in elderly patients with lower respiratory tract infection.
Community-based study. Arch Intern Med, 157 (1997), pp. 2190-2195
[30.]
M.J. Fine, M.A. Smith, C.A. Carson, et al.
Prognosis and outcomes of patients with community-acquired pneumonia.
A meta-analysis. JAMA, 275 (1996), pp. 134-141
[31.]
T.J. Marrie, W. Blanchard.
A comparison of home-acquired pneumonia patients with community-acquired pneumonia and nursing home patients without pneumonia.
J Am Geriatr Soc, 45 (1997), pp. 50-55
[32.]
J. Rello, R. Rodriguez, P. Jubert, et al.
Severe community-acquired pneumonia in the elderly: epidemiology and prognosis.
Clin Infect Dis, 23 (1996), pp. 723-728
[33.]
R. Riquelme, A. Torres, M. El-Ebiary, et al.
Community-acquired pneumonia in the elderly: Clinical and nutritional aspects.
Am J Respir Crit Care Med, 156 (1997), pp. 1908-1914
[34.]
Irma Koivula, Marja Sten, Pirjo Helena Makela.
Prognosis after community-acquired pneumonia in the elderly: a population-based 12-year follow-up study.
Arch Intern Med, 159 (1999), pp. 1550-1555
[35.]
A. Ortqvist, J. Hedlund, L.-A. Burman, et al.
Randomised trial of 23-valent pneumococcal capsular polysaccaride vaccine in prevention of pneumonia in middle-aged and elderly people.
Lancet, 351 (1998), pp. 399-403
[36.]
G. Bolan, C.V. Broome, R.R. Facklam, et al.
Pneumococcal vaccine efficacy in selected populations in the United States.
Ann Intern Med, 104 (1986), pp. 1-6
[37.]
E.D. Shapiro, A.T. Berg, R. Austrian, et al.
The protective efficacy of polyvalent pneumococcal polysacharide vaccine.
N Engl J Med, 325 (1991), pp. 1453-1460
Copyright © 2001. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
- Comparison of different field tests to assess the physical capacity of post-COVID-19 patients
- New insights in circulating peptidome to differentiate mild to severe COVID-19 patients: Preliminary report
Recommended
articles
articles
10.1016/j.pulmoe.2023.01.004
Pulmonol. 2023;29:362-74
Pulmonol. 2023;29:315-22
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options